MHRA consults on new framework to boost rare disease therapies

21st May 2026

Summary:
The MHRA has launched a consultation on a new regulatory framework designed to accelerate the development and approval of therapies for rare diseases. The proposals focus on creating a more flexible and proportionate system that supports innovation while maintaining patient safety. Key elements include streamlining clinical trial requirements, improving regulatory pathways, and enhancing collaboration with international partners and stakeholders. The initiative reflects the UK’s ambition to become a leading environment for life sciences and to address the unmet needs of patients with rare conditions more effectively. The consultation invites feedback from industry, researchers, and the public to help shape the final approach.

Link: https://www.gov.uk/government/news/mhra-consults-on-new-regulatory-framework-to-make-uk-a-global-leader-in-rare-disease-therapy-development

Back to Recent News